Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Beta Bionics, Inc. (BBNX) had Weighted-Average Shares Outstanding (Diluted) of 40.53M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$100.25M |
|
$-73.20M |
|
$44.71M |
|
$55.54M |
|
$171.93M |
|
$-71.68M |
|
$-1.52M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-73.20M |
|
$-71.68M |
|
$-68.81M |
|
40.53M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.53M |
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$267.90M |
|
$8.60M |
|
$60.84M |
|
$328.74M |
|
$30.92M |
|
-- |
|
$10.21M |
|
$41.13M |
|
$287.61M |
|
$287.61M |
|
$287.61M |
|
44.36M |
|
| Cash Flow Statement Financials | |
$-50.92M |
|
$-162.81M |
|
$214.87M |
|
$30.53M |
|
$31.68M |
|
$1.14M |
|
$16.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
55.40% |
|
-71.50% |
|
-71.50% |
|
-68.63% |
|
-73.02% |
|
-73.02% |
|
$-332.96M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
2.06 |
|
5.86 |
|
62.32 |
|
-25.45% |
|
-25.45% |
|
-22.27% |
|
-25.45% |
|
$6.48 |
|
$-8.22 |
|
$-1.26 |
|